Nasdaq · Healthcare

Nano-X Imaging Ltd. (NNOX)

As-reported financials and recent SEC filings for Nano-X Imaging Ltd., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$13.0M

Net income

$-75.0M

Net margin

—

Diluted EPS

$-1.16

ROE

-53.7%

P/E (TTM)

—

Market cap

—

Debt / equity

—

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$13.0M	$11.3M	$9.9M	$8.6M	$1.3M
Gross profit	$-12.8M	$-10.6M	$-6.6M	$-6.9M	$-1.5M
Operating income	$-78.2M	$-56.7M	$-62.6M	$-117.7M	$-61.6M
Net income	$-75.0M	$-53.5M	$-60.8M	$-113.2M	$-61.8M
Diluted EPS	$-1.16	$-0.91	$-1.08	$-2011.59	$-1.10

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

6-K2026-06-25

View on EDGAR →

42026-06-15

View on EDGAR →

SCHEDULE 13G/A2026-05-15

20-F2026-04-30

32026-04-30

6-K2026-04-20

32026-04-09

32026-04-07

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on NNOX

Search Nano-X Imaging Ltd.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.